Breaking News

NuVasive Launches New Spinal Trauma Portfolio

By PR Newswire | April 20, 2017

RELINE Trauma provides surgeons the flexibility to customize their approach intra-operatively.

NuVasive Inc., a medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, has announced the launch the new RELINE Trauma portfolio, which will serve as the company's foundation to address the estimated $100 million U.S. spine trauma fixation market, currently growing 5.6 percent annually.
Spine trauma cases are performed approximately 90 percent open and only 10 percent minimally-invasive. RELINE Trauma is the first trauma system designed to provide surgeons the flexibility to customize their approach intra-operatively, including traditional open, MAS (Maximum Access Surgery) or hybrid procedures, depending on the pathology and patient needs. Developed by the leader in minimally disruptive spine technology, the Company's new trauma system supports surgeons in the increasing transition from open to MAS spine procedures. 
The system offers surgeons the ability to customize implant types and supports a multitude of techniques, depending on surgeon preference. Also, RELINE Trauma enhances the surgeon's ability to dial-in fracture correction through a dual rack system achieving independent lordosis restoration and parallel compression/distraction for ligamentotaxis. This enables procedures to be completed by one surgeon rather than two, helping reduce the total cost of the procedure.
"The versatility of the new RELINE Trauma system allows me to address trauma surgery circumferentially," said Juan Uribe, M.D., associate professor, Department of Neurosurgery, University of South Florida College of Medicine, Tampa, Florida. "NuVasive has removed the need for a second surgeon and eliminated hours in comparison to the alternative technique. RELINE Trauma is a game-changer in spine."
In addition, the RELINE Trauma Fracture Frame instrumentation allows for controlled fracture correction throughout the procedure, with or without a rod present in the construct. The systems also allow surgeons the ability to place various rod diameters and/or materials before or after fracture correction, greatly improving the ability to reduce fractures more easily and reproducibly.
"The launch of RELINE Trauma is a key milestone in our continued commitment to industry-leading innovation that delivers untapped clinical and economic value for our surgeon partners," said Jason Hannon, president and chief operating officer of NuVasive. "RELINE Trauma will help define the standard of trauma care for spine, with its ability to dramatically reduce time and provide complete versatility intra-operatively. The system will be the foundation of our trauma portfolio as we invest further in this key market."
RELINE Trauma is further integrated with proprietary NuVasive Computer Assisted Technologies such as NVM5, NuvaLine, NuvaMap, and NuvaMap O.R., all within the Integrated Global Alignment (iGA) platform. iGA allows surgeons to calculate, correct and confirm spinal alignment through preoperative planning, intraoperative assessment, and postoperative confirmation for their trauma cases. Additionally, constructs are further enhanced with the integration of the Bendini system which expedites manual rod manipulation via computer-assisted bend instructions.

Related News:

Related Markets:

  • Loading Orthopedic Devices with Biologics and Pharmaceuticals

    Loading Orthopedic Devices with Biologics and Pharmaceuticals

    Dr. Kevin Nelson, Founder and CSO, TissueGen Inc.||May 19, 2017
    Fiber technology enables the delivery of the therapeutic components via a biodegradable platform that can be implanted.

  • Looking Beneath the Surface

    Looking Beneath the Surface

    Sam Brusco, Associate Editor||May 19, 2017
    Surface treatments seek to improve orthopedic device usability, longevity, and bone integration.

  • Going to Extremes

    Going to Extremes

    Michael Barbella, Managing Editor||May 19, 2017
    The innovation and market value found in extremity solutions is prompting a change of heart among major orthopedic firms.